Difficult-to-treat inflammatory bowel disease: results from a global IOIBD survey-Reference-Cited by-同舟云学术

Difficult-to-treat inflammatory bowel disease: results from a global IOIBD survey

Published:2022-05 Issue:5 Volume:7 Page:390-391
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Parigi Tommaso Lorenzo,D'Amico Ferdinando,Abreu Maria T,Rubin David T,Dignass Axel,Dotan Iris,Jairath Vipul,Magro Fernando,Peyrin-Biroulet Laurent,Ghosh Subrata,Danese Silvio

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference1 articles.

1. Defining difficult-to-treat inflammatory bowel disease: why and how;Danese;Lancet Gastroenterol Hepatol,2021

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microbial metabolite deoxycholic acid-mediated ferroptosis exacerbates high-fat diet-induced colonic inflammation;Molecular Metabolism;2024-06

2. Enteral nutrition compared with corticosteroids in children with Crohn's disease: A long‐term nationwide study from the epi‐IIRN;Alimentary Pharmacology & Therapeutics;2024-05-14

3. Gut microbiota and metabolites as predictors of biologics response in inflammatory bowel disease: A comprehensive systematic review;Microbiological Research;2024-05

4. Difficult‐to‐treat inflammatory bowel disease: Effectiveness and safety of 4th and 5th lines of treatment;United European Gastroenterology Journal;2024-04-09

5. Effectiveness of Partial Enteral Nutrition as Add-On to Biologics in Patients With Refractory and Difficult-to-Treat Crohn’s Disease: A Pilot Study;Crohn's & Colitis 360;2024-01-01